These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7435510)

  • 1. Propensity for spontaneous nucleation of calcium oxalate. Quantitative assessment by urinary FPR-APR discriminant score.
    Pak CY; Galosy RA
    Am J Med; 1980 Nov; 69(5):681-9. PubMed ID: 7435510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple technique for assessing the propensity for crystallization of calcium oxalate and brushite in urine from the increment in oxalate or calcium necessary to elicit precipitation.
    Nicar MJ; Hill K; Pak CY
    Metabolism; 1983 Sep; 32(9):906-10. PubMed ID: 6888271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurements of urinary state of saturation with respect to calcium oxalate and brushite (CaHPO4.2H2O) in renal stone formers.
    Sriboonlue P; Prasongwattana V; Tungsanga K; Sitprija V
    J Med Assoc Thai; 1990 Dec; 73(12):684-9. PubMed ID: 2086716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prolonged bedrest on the propensity for renal stone formation.
    Hwang TI; Hill K; Schneider V; Pak CY
    J Clin Endocrinol Metab; 1988 Jan; 66(1):109-12. PubMed ID: 3335600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary supersaturation with respect to brushite in patients suffering calcium oxalate lithiasis.
    Berland Y; Boistelle R; Olmer M
    Nephrol Dial Transplant; 1990; 5(3):179-84. PubMed ID: 2113644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleation and growth of brushite and calcium oxalate in urine of stone-formers.
    Pak CY; Holt K
    Metabolism; 1976 Jun; 25(6):665-73. PubMed ID: 1272073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of parathyroidectomy on crystallization of calcium salts in urine of patients with primary hyperparathyroidism.
    Pak CY
    Invest Urol; 1979 Sep; 17(2):146-8. PubMed ID: 468514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Parker WR; Asplin JR
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence justifying a high fluid intake in treatment of nephrolithiasis.
    Pak CY; Sakhaee K; Crowther C; Brinkley L
    Ann Intern Med; 1980 Jul; 93(1):36-9. PubMed ID: 7396311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new urinary test for stone "activity".
    Hallson PC; Rose GA
    Br J Urol; 1978 Dec; 50(7):442-8. PubMed ID: 753493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine risk factors in children with calcium kidney stones and their siblings.
    Bergsland KJ; Coe FL; White MD; Erhard MJ; DeFoor WR; Mahan JD; Schwaderer AL; Asplin JR
    Kidney Int; 2012 Jun; 81(11):1140-8. PubMed ID: 22358148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential arterial hypertension and stone disease.
    Borghi L; Meschi T; Guerra A; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-Term Tolvaptan Increases Water Intake and Effectively Decreases Urinary Calcium Oxalate, Calcium Phosphate and Uric Acid Supersaturations.
    Cheungpasitporn W; Erickson SB; Rule AD; Enders F; Lieske JC
    J Urol; 2016 May; 195(5):1476-1481. PubMed ID: 26598423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of magnesium oxide on the crystallization of calcium salts in urine in patients with recurrent nephrolithiasis.
    Fetner CD; Barilla DE; Townsend J; Pak CY
    J Urol; 1978 Oct; 120(4):399-401. PubMed ID: 702659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of inhibitor and nucleator activities in calcium stone formers.
    Duranti E; Imperiali P; Badii M; Capiccioni S; Masi MG; Sasdelli M
    Proc Eur Dial Transplant Assoc; 1983; 20():445-9. PubMed ID: 6657667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.